Nanoengineered implant as a new platform for regenerative nanomedicine using 3D well-organized human cell spheroids
Keller, L. ; Idoux-Gillet, Y. ; Wagner, Q. ; Eap, S. ; Brasse, D. ; Schwinté, P. ; Arruebo, M. (Universidad de Zaragoza) ; Benkirane-Jessel, N.
Resumen: In tissue engineering, it is still rare today to see clinically transferable strategies for tissue-engineered graft production that conclusively offer better tissue regeneration than the already existing technologies, decreased recovery times, and less risk of complications. Here a novel tissue-engineering concept is presented for the production of living bone implants combining 1) a nanofibrous and microporous implant as cell colonization matrix and 2) 3D bone cell spheroids. This combination, double 3D implants, shows clinical relevant thicknesses for the treatment of an early stage of bone lesions before the need of bone substitutes. The strategy presented here shows a complete closure of a defect in nude mice calvaria after only 31 days. As a novel strategy for bone regenerative nanomedicine, it holds great promises to enhance the therapeutic efficacy of living bone implants.
Idioma: Inglés
DOI: 10.2147/IJN.S116749
Año: 2017
Publicado en: International Journal of Nanomedicine 12 (2017), 447-457
ISSN: 1176-9114
Factor impacto JCR: 4.37 (2017)
Categ. JCR: PHARMACOLOGY & PHARMACY rank: 31 / 261 = 0.119 (2017) - Q1 - T1
Categ. JCR: NANOSCIENCE & NANOTECHNOLOGY rank: 35 / 92 = 0.38 (2017) - Q2 - T2
Factor impacto SCIMAGO: 1.225 - Bioengineering (Q1) - Biomaterials (Q1) - Biophysics (Q1) - Organic Chemistry (Q1) - Medicine (miscellaneous) (Q1) - Drug Discovery (Q1) - Nanoscience and Nanotechnology (Q2)
Tipo y forma: Article (Published version)
Área (Departamento): Área Ingeniería Química (Dpto. Ing.Quím.Tecnol.Med.Amb.)
You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes.
Exportado de SIDERAL (2019-07-09-11:38:34)
Visitas y descargas
Idioma: Inglés
DOI: 10.2147/IJN.S116749
Año: 2017
Publicado en: International Journal of Nanomedicine 12 (2017), 447-457
ISSN: 1176-9114
Factor impacto JCR: 4.37 (2017)
Categ. JCR: PHARMACOLOGY & PHARMACY rank: 31 / 261 = 0.119 (2017) - Q1 - T1
Categ. JCR: NANOSCIENCE & NANOTECHNOLOGY rank: 35 / 92 = 0.38 (2017) - Q2 - T2
Factor impacto SCIMAGO: 1.225 - Bioengineering (Q1) - Biomaterials (Q1) - Biophysics (Q1) - Organic Chemistry (Q1) - Medicine (miscellaneous) (Q1) - Drug Discovery (Q1) - Nanoscience and Nanotechnology (Q2)
Tipo y forma: Article (Published version)
Área (Departamento): Área Ingeniería Química (Dpto. Ing.Quím.Tecnol.Med.Amb.)
You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. Exportado de SIDERAL (2019-07-09-11:38:34)
Permalink:
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
Articles
Record created 2017-03-22, last modified 2019-07-09